Hepatitis B virus persistence and reactivation

Y Shi, M Zheng - bmj, 2020 - bmj.com
Hepatitis B virus (HBV) infection causes chronic hepatitis and has long term complications.
Individuals ever infected with HBV are at risk of viral reactivation under certain …

[PDF][PDF] Hepatitis B: the virus and disease

TJ Liang - Hepatology, 2009 - Wiley Online Library
Hepatitis B virus (HBV) infects more than 300 million people worldwide and is a common
cause of liver disease and liver cancer. HBV, a member of the Hepadnaviridae family, is a …

Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

M Tomblyn, T Chiller, H Einsele, R Gress… - Bone marrow …, 2009 - nature.com
Guidelines for preventing infectious complications among hematopoietic cell transplant
recipients: a global perspective | Bone Marrow Transplantation Skip to main content Thank you …

The influence of bio-behavioural factors on tumour biology: pathways and mechanisms

MH Antoni, SK Lutgendorf, SW Cole, FS Dhabhar… - Nature reviews …, 2006 - nature.com
Epidemiological studies indicate that stress, chronic depression and lack of social support
might serve as risk factors for cancer development and progression. Recent cellular and …

Hepatitis B virus screening and management for patients with cancer prior to therapy: ASCO provisional clinical opinion update

JP Hwang, JJ Feld, SP Hammond, SH Wang… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE This Provisional Clinical Opinion update presents a clinically pragmatic
approach to hepatitis B virus (HBV) screening and management. PROVISIONAL CLINICAL …

Management of patients with hepatitis B who require immunosuppressive therapy

JP Hwang, ASF Lok - Nature reviews Gastroenterology & hepatology, 2014 - nature.com
Patients with chronic HBV infection are at risk of reactivation of HBV should they require
immunosuppressive therapies for a variety of clinical settings, including chemotherapy for …

Occult HBV infection

G Raimondo, T Pollicino - Hepatitis B virus in human diseases, 2016 - Springer
The long-lasting persistence of HBV genomes in the liver (and in some cases also in the
serum) of HBsAg negative subjects is termed occult HBV infection (OBI). This peculiar …

[PDF][PDF] Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

W Yeo, PJ Johnson - Hepatology, 2006 - Wiley Online Library
It is estimated conservatively that more than one third of the world's population has been
infected with the hepatitis B virus (HBV) and that there are 350 million people with chronic …

Kinetics and risk of de novo hepatitis B infection in HBsAg–negative patients undergoing cytotoxic chemotherapy

CK Hui, WWW Cheung, HY Zhang, WY Au, YH Yueng… - Gastroenterology, 2006 - Elsevier
Background & Aims: De novo hepatitis B virus (HBV)-related hepatitis after chemotherapy
results in high morbidity and mortality. We evaluate the clinical course of de novo HBV …

Infection risk associated with anti-TNF-α agents: a review

G Murdaca, F Spanò, M Contatore… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: TNF-α is a pro-inflammatory cytokine known to a have a key role in the
pathogenesis of chronic immune-mediated diseases. TNF-α inhibitors can be administered …